Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Janssen's Topamax Users Blame Drug for Birth Defects
Bloomberg
Tuesday, October 15, 2013 - 4:58pm
tags:
Janssen, Topamax, JNJ, birth defects
3 Ways Q3 Results Show How J&J Is Dramatically Changing
Motley Fool
Tuesday, October 15, 2013 - 4:57pm
tags:
JNJ, earnings
GlaxoSmithKline boss calls for £1bn university fund to back invention
The Guardian, UK
Tuesday, October 15, 2013 - 11:58am
tags:
Andrew Witty, GSK, R&D
New Data Show Omontys At Least 4x Worse Than Reported: Now 22 Suspected Deaths
Seeking Alpha
Tuesday, October 15, 2013 - 11:54am
tags:
Omontys, Affymax, recalls
Arena's Belviq Refill Tracking - Week 17
Seeking Alpha
Tuesday, October 15, 2013 - 11:44am
tags:
Arena Pharmaceuticals, Belviq, Eisai
Roche to supersize biologics production to meet biologics' super forecasts
Fierce Pharma
Tuesday, October 15, 2013 - 11:42am
tags:
Roche, biologics
Sotera lands FDA OK for wireless blood pressure monitor
Mass Device
Tuesday, October 15, 2013 - 11:41am
tags:
Sotera, FDA, wireless blood pressure monitor, devices
Reports: Medical device tax is off the table
Mass Device
Tuesday, October 15, 2013 - 11:38am
tags:
healthcare reform, device tax, devices
Omeros gets approval to study eye surgery drug in children; could extend marketing exclusivity
Yahoo/AP
Tuesday, October 15, 2013 - 11:36am
tags:
Omeros, eye surgery, OMS302
The Chinese Bribery Scandal Is Hurting Big Pharma
Forbes
Tuesday, October 15, 2013 - 11:32am
tags:
China, Big Pharma
4 Biotechnology Stocks With Room To Climb
Seeking Alpha
Tuesday, October 15, 2013 - 10:23am
tags:
Zalicus, Vical, Discovery Labs, Nanosphere
What Drugs? Sanofi Battles Employees In France Over R&D Job Cuts
Pharmalot
Tuesday, October 15, 2013 - 10:21am
tags:
Sanofi, layoffs, R&D
Merck - Little Appeal Despite Recently Announced Cost Cuts
Seeking Alpha
Tuesday, October 15, 2013 - 10:20am
tags:
Merck, Pfizer, Zoetis
This New Cholesterol Treatment Has Blockbuster Potential
Motley Fool
Tuesday, October 15, 2013 - 10:09am
tags:
Alnylam, gene silencing, Pfizer, statins, ALN-PCS
AstraZeneca to Pay Up to $440 Million for Spirogen
Bloomberg
Tuesday, October 15, 2013 - 9:39am
tags:
Spirogen, AstraZeneca, M&A, antibody-drug conjugate, ADC Therapeutics, MedImmune
Savient Pharmaceuticals Files for Bankruptcy Protection
Bloomberg
Tuesday, October 15, 2013 - 9:35am
tags:
Savient, bankruptcy
US FDA inspectors face "huge backlog" when shutdown eventually ends says ASF
In-Pharmatechnologist
Tuesday, October 15, 2013 - 9:35am
tags:
FDA
Pharmacyclics' Ibrutinib Could Crown Its Turnaround Story
Investors.com
Tuesday, October 15, 2013 - 8:55am
tags:
Pharmacyclics, ibrutinib
Why The FDA Probably Won't Approve An Expanded Indication For Amarin's Vascepa
Forbes
Tuesday, October 15, 2013 - 8:40am
tags:
FDA, Vascepa, Amarin
Novogen Is Poised To Soar As A Major Partnership Announcement Is Imminent
Seeking Alpha
Tuesday, October 15, 2013 - 8:39am
tags:
Novogen, Bristol-Myers Squibb, Merck, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.